James Angus Wilson (Bilkstys-) Richardson

James Angus Wilson (Bilkstys-) Richardson appears in our data through filings on NurExone Biologic Inc. (formerly, EnerSpar Corp.) shares, published by SEDI. Over a trading history stretching from 14 June 2024 to 22 December 2025, the count stands at 19 filings.

The open-market side counts 5 purchases for €4,519 alongside 12 sales for €45k. The net balance comes to €40k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2025 to date brings 5 purchases and 9 sales.

A typical purchase (the median) is worth €637. The 5 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The record was last updated on 22 December 2025 with an open-market sale (€4,210) in NurExone Biologic Inc. (formerly, EnerSpar Corp.). The latest purchase dates back some time: it was published 322 days ago, on 3 December 2025. The median gap between a trade and its publication by SEDI is 1 day. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.